miR-124 and miR-506 inhibit colorectal cancer progression by targeting DNMT3B and DNMT1

Abstract

// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Zhiheng Chen1, Shaojun Liu2, Li Tian2, Minghao Wu4, Feiyan Ai2, 3, Wuliang Tang2, Lian Zhao2, 3, Juan Ding5, Liyang Zhang6, Anliu Tang2, 3 1Department of Pediatrics, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China 2Department of Gastroenterology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China 3Hunan Key Laboratory of Nonresolving Inflammation and Cancer, Changsha, Hunan, China 4Department of Gastroenterology, The Hunan Provincial People's Hospital, Changsha, Hunan, China 5Department of Oncology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China 6Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, China Correspondence to: Anliu Tang, e-mail: tanganliu@163.com Liyang Zhang, e-mail: zhangliyang_csu@163.com Keywords: miR-124, miR-506, colorectal cancer, DNMT3B, DNMT1 Received: May 29, 2015 Accepted: October 05, 2015 Published: October 15, 2015